Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on diet & genetics. Browse all Diet & Genetics education

The SLC2A2 gene carries the code for GLUT2, a glucose transporter that acts as one of the body’s sugar sensors. A common variant in this gene, rs5400 (a Thr110Ile amino-acid change), has drawn research attention because it appears to influence how much sugar people prefer to eat — with downstream implications for blood sugar, the liver, and body weight.

What SLC2A2 and GLUT2 actually do

GLUT2 sits in the membranes of cells in the pancreas, liver, intestine, kidney, and parts of the brain. Unlike transporters that only move glucose in one direction, GLUT2 lets glucose flow according to its concentration, making it an ideal sensor. In the pancreas it helps trigger insulin release; in the brain it contributes to signaling that shapes appetite and sugar preference; in the liver it participates in glucose uptake and release.

The rs5400 variant and sugar intake

Several nutritional-genetics studies have reported that carriers of the rs5400 (Ile110) allele tend to consume more sugar and sugar-sweetened foods than non-carriers. The leading hypothesis is that altered GLUT2 glucose sensing in the brain nudges preference toward sweeter foods. The effect sizes are modest and vary across populations, but the association has been replicated in more than one cohort, making SLC2A2 a recurring name in the study of dietary behavior.

rs5400 and blood sugar regulation

Because GLUT2 helps the pancreas sense glucose and release insulin, variants in SLC2A2 have been examined for links to glucose handling and type 2 diabetes risk. Rare severe SLC2A2 mutations cause Fanconi-Bickel syndrome, a condition of disordered glucose metabolism — evidence of how central this transporter is. For the common rs5400 variant, any effect on blood sugar is small and works alongside stronger diabetes-risk genes such as TCF7L2.

Liver health and metabolic load

The liver relies on GLUT2 to move glucose in and out as it balances energy storage and release. Diets high in added sugar and fructose increase the metabolic workload on the liver and are associated with fat accumulation. While rs5400 itself is not a liver-disease gene, a genetically nudged preference for higher sugar intake can, over years, contribute to the dietary patterns linked with metabolic strain — which is why the behavioral angle matters more than the transporter alone.

Body weight and appetite

Sugar preference feeds into calorie intake, and calorie intake feeds into weight. SLC2A2 sits alongside better-known appetite and weight genes such as FTO and MC4R in the broader map of eating behavior. None of these variants dictate weight; they shift the baseline tendencies that diet, activity, sleep, and environment then act on. A person carrying the rs5400 allele is not destined to gain weight — but if a stronger pull toward sweet foods goes unrecognized, it can quietly shape years of eating patterns. That is precisely why seeing the tendency in advance can make dietary strategies more targeted, realistic, and easier to sustain.

What genetic pathway context can add

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including metabolic and appetite-related pathways that involve genes like SLC2A2, FTO, and TCF7L2. It reports pathway-level context about your biology — not a diagnosis and not a diet prescription. Results are designed to inform a conversation with a qualified provider or dietitian who can help translate tendencies into a plan.

Frequently Asked Questions

Does the SLC2A2 rs5400 variant mean I will crave sugar?

Carriers of the rs5400 Ile110 allele tend, on average, to consume more sugar in research studies, likely due to altered GLUT2 glucose sensing in the brain. The effect is a modest tendency, not a certainty. Diet, habits, and environment strongly shape actual sugar intake regardless of genotype.

Does rs5400 cause diabetes or fatty liver?

No. The common rs5400 variant is not a disease-causing mutation. It is one small influence on sugar preference that can indirectly affect metabolic load over time. Stronger genes like TCF7L2, plus diet and lifestyle, carry far more weight in blood sugar and liver health outcomes.

Can I offset a sugar-preference variant?

Yes. Genotype sets a starting tendency, not a fixed outcome. Structured meals, adequate protein and fiber, mindful reduction of added sugar, and support from a dietitian all work regardless of SLC2A2 status. Knowing your tendency can make these strategies more targeted.

Curious how your own biology maps to these pathways? The Precision Peptide Genetic Test gives you pathway-level genetic context to bring into an informed conversation with your healthcare provider — test before you invest.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not diagnose, treat, cure, or prevent any condition, and it does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Diet & Genetics education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves